ADVM
Adverum Biotechnologies Inc.
Latest News for ADVM
An announcement from Adverum Biotechnologies ( ($ADVM) ) is now available. On November 20, 2025, Adverum Biotechnologies received a termination not......
Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Adverum Biotechnologies today and set a price target of $5.50. The company’s......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cabaletta Bio (CABA – Research Report), Actinium P......
RBC Capital analyst Lisa Walter maintained a Hold rating on Adverum Biotechnologies yesterday and set a price target of $4.00. The company’s shares......
Adverum Biotechnologies (($ADVM)) announced an update on their ongoing clinical study. Adverum Biotechnologies is conducting a Phase 3 clinical stu......
Eli Lilly ($LLY) is strengthening its presence in genetic medicine with a deal worth $261.7 million to acquire Adverum Biotechnologies ($ADVM), a c......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADVM | $4.14 | -1.2% | 206.45K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Adverum Biotechnologies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW